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Abstract
Development of a Simplified Pediatric Obstructive Sleep Apnea (OSA) Screening Tool
By Jo Koontz Cronly, DDS
A thesis submitted in partial fulfillment of the requirements for the degree of Master of Science
in Dentistry at Virginia Commonwealth University.
Virginia Commonwealth University, 2014
Thesis Advisor: Harmeet Chiang, DDS
ASSOCIATE PROFESSOR, DEPARTMENT OF GENERAL DENTISTRY
Background: Obstructive sleep apnea has become recognized as one of the most common,
under-diagnosed chronic diseases. Recently studies have shown increased numbers among the
pediatric and adolescent population. OSA in children is associated with behavioral problems,
poor school achievements, and in severe cases, pulmonary hypertension. OSA is often the
Achilles heel of pediatric sedation and analgesic programs; during sedation, children with OSA
have an increased vulnerability of their airway undergoing pharyngeal collapse and of having
upper airway obstruction. Consequently, pediatric dentists who practice sedation dentistry should
exercise extra precautions when treating patients with risk of sleep apnea. Currently there is no
screening tool used in pediatric dentistry for diagnosing OSA during the pre-operative
appointment or consultation for patients undergoing minimal and moderate oral conscious
sedation. The purpose of this study was to develop and test a concise and easy-to-use
questionnaire as a screening tool to aid in the diagnosis of OSA in pediatric patients. Materials
and Methods: A retrospective chart review of 180 patients under the age of 18, who completed a
polysomnogram at the VCU Center for Sleep Medicine between February 2011 and February
2013. A validated adult questionnaire, STOPBANG, was modified using more typical pediatric
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risk factors for OSA: presence of snoring (S), tonsillar hypertrophy (T1), tiredness; pESS>10
(T2), observed obstruction (O), neuroPsych-behavioral symptoms such as ADHD or daytime
irritability (P), BMI percentile for age (B), age at diagnostic screening (A), presence of
neuromuscular disorder (N), and presence of genetic/congenital disorder (G). A positive scoring
from these variables was measured against the standard OSA measure, Apnea-Hypopnea Index.
A multiple logistic regression analysis tested for relationships.
Results: There was a statistically significant relationship P= .0007 for the S(T1)OPBANG scale,
with a minimum of 4 variables needed to have a sensitivity of 57% and a specificity of 78%.
There was also a statistically significant relationship P= .0040 for the S(T2)OPBANG, the
cutoff>5 yielding sensitivity=36%, and specificity=90%. Only obstruction, BMI, and age
showed a strong significant relationship to OSA. The presence of an obstruction was positively
related to apnea (P = 0.0010). Most of the other components had an odds-ratio larger than one
(indicating a nominally positive relationship). Conclusions: While both STOPBANG screening
tools showed a statistically significant relationship, only obstruction, BMI, and age showed a
predictive relationship to OSA. Consequently, consideration of other risk factors may be
beneficial for future studies.

Introduction

Sleep-disordered breathing encompasses a wide range of upper airway disorders from primary
snoring (PS) to obstructive sleep apnea (OSA). OSA results from impedance to air flow in the
upper airway during sleep; these periodic obstructions of the upper airway interfere with normal
respiratory gas exchange and subsequently interrupt sleep.1,2 OSA is measured by the ApneaHypopnea index, which represents the total apneas and hypopneas per hour of sleep.3 Apnea
denotes the cessation of airflow and is classified based on the pattern of respiratory effort.
Hypopnea is a reduction in airflow.4
OSA has become recognized as one of the most common, under-diagnosed chronic
diseases.5-7 People of all ages are affected with OSA, recently studies have shown increased
numbers among the pediatric and adolescent population.8 The prevalence of obstructive sleep
apnea (OSA) in children is estimated to be 1-3%,9 while primary snoring occurs in 3-12% of the
pediatric population.10 A child with an AHI of greater than 5 events an hour emerges as having
clinically significant OSA.11 Even brief obstructive apneas may be associated with significant
hypoxemia due to children having a faster respiratory rate and lower functional residual capacity
than adults.12 Mild cases of pediatric OSA are recognized and at times treated; however,
measurable effects on development, cardiopulmonary or metabolic systems have been difficult to
validate. OSA is associated with behavioral problems, poor school achievements, and in severe
cases, pulmonary hypertension.2 Many studies have been conducted to identify adverse effects of
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sleep disorders, yet few studies have examined how health care providers may identify and treat
sleep disorders.13
Dentists who see their patients more frequently than their primary care doctors have a
greater opportunity to observe signs and symptoms of OSA.8 However many potential sleep
disorders in children are unrecognized and under-reported, and overall the condition is underdiagnosed.14 Dentists who practice sedation dentistry should exercise extra precautions when
treating patients with risk of sleep apnea. Minimal and moderate oral conscious sedation and
general anesthesia are commonly used in pediatric dentistry; thus pediatric dentists have an acute
responsibility to be able to identify patients who may have OSA.7 During sedation, children with
OSA have an increased vulnerability of their airway undergoing pharyngeal collapse and of
having upper airway obstruction.9 The risk of postoperative respiratory complications amongst
the pediatric population ranges from 0 to 1.3%; however for children with OSA the rates have
been reported to be 16-27%.15,16 The incidence of OSA in children is most elevated between ages
2 to 6 years old. In this age range pharmacologic measures are most often used to complete
diagnostic and therapeutic procedures.9
While polysomnography (PSG) remains the gold standard to diagnose OSA, there are
many challenges due to the limited number of sleep laboratories and the high cost of using PSG
on each child who snores and may be at risk.10 Polysomnography provides information
pertaining to sleep patterns but fails to identify behavioral sleep disturbances.17 Available nonPSG screening tests have poor sensitivity for milder OSA, and overall poor specificity.10 In
extreme cases of OSA the clinical severity is easily determined with or without PSG, however it
is the mild to moderate cases that are most difficult to diagnose. Moreover, there remains a
challenge to differentiate PS from OSA in a “cost-effective, reliable, and accurate manner before
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recommending invasive or intrusive therapies, such as surgery or continuous positive airway
pressure”.10
Sleep questionnaires that are completed by the parent and child are a crucial component of
behavioral and physiological sleep assessment. Pediatric questionnaires are mostly retrospective
in that the parents report on past sleep patterns and behaviors that are typical of their child.
Questionnaires have been used alone or with other sleep assessment tools. Within the last 20
years, the number of pediatric sleep questionnaires has greatly increased.17 Moreover, a review
of sleep questionnaires from 2011 stated that there were “too many tools being used that have not
undergone careful and methodical psychometric evaluation, and as such may be fraught with
biased or invalid findings”.18
In 2008, Chung et al developed and validated a STOP questionnaire as a screening tool
for OSA in patients 18 years and older. This questionnaire asks four yes or no questions: do you
snore loudly?, do you feel tired during the daytime?, has anyone observed you stop breathing
during your sleep?, and do you have high blood pressure? These questions along with body mass
index, age, neck size, and gender (BANG) were found to have a sensitivity of 83.6, 92.9, and
100% (for mild, moderate, and severe OSA, respectively).19 In 2006, the American Society of
Anesthesiologists (ASA) Task Force on Perioperative Management of Patients with Obstructive
Sleep Apnea recommended a checklist as a routine screening tool to utilize in surgical patients
who may have OSA. The ASA checklist has 12 items for adults and 14 items for children, but
was only validated by Chung for its use on adults.20
In 2011 Spruyt and Gozal published a review on Pediatric sleep questionnaires that
examined 57 sleep measures that were used to screen children for sleep disorders including
OSA.18 Only 2 questionnaires fulfilled all desirable criteria: The Sleep Disturbance Scale for
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Children (SDSC) at a cut-off score of 39 provided a sensitivity of 0.89 and a specificity of 0.74
21

; and The Sleep Disorders Inventory for Students-Children (SDIS-C) showed a sensitivity of

0.91 and a specificity of 0.62 for the category of Obstructive Sleep Apnea Syndrome.22 This
review documented that few standardized screening tools exist thus far to determine risk for
OSA in children.18 Pediatric Dentists and anesthesiologists alike would benefit from a standard
screening tool, similar to the STOPBANG, to determine if OSA may exist in potential sedation
and anesthesia pediatric patients.
Complications arise with diagnosing pediatric OSA because its presentation can differ
from that of an adult. The exact pathophysiology of OSA in children has not been determined but
it appears to result from both upper airway narrowing and upper airway hypotonia. Thus children
with craniofacial abnormalities and neuromuscular disorders are at increased risk. The patency of
the upper airway depends on pharyngeal dilating muscles. Children with neuromuscular diseases
frequently present upper muscle airway weakness that can cause the airway to collapse. Upper
airway narrowing is often a result of adenotonsillar hypertrophy. Despite past studies in which
children with OSA typically have larger tonsils and adenoids than children who do not, the size
of tonsils and adenoids does not predict the disease in individual persons. While excessive
daytime sleepiness is a major complaint in adults with OSA, it is less common in children. This
is most likely due to children maintaining their sleep architecture as they have a higher waking
threshold than adults. Snoring has also been noted in both children and adults who have OSA. In
prepubertal children, OSA occurs equally in both genders. However in adults, OSA occurs twice
as often in males as in females. A large predisposing factor to OSA in adults is obesity. Obesity
also appears to be a risk factor in children.12 Capdevila proposed the existence of two distinct
types of OSA in children. Type I is associated with adenotonsillar hypertrophy in the absence of
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obesity. Type II presents with “milder upper airway lymphadenoid hyperplasia” and obesity.23 It
is fundamental to be able to identify both phenotypes that my present with signs of OSA.
OSA is often the Achilles heel of pediatric sedation and analgesic programs,9 thus it is
imperative that pediatricians and pediatric dentists be able to identify a child who may be at risk
for OSA so that appropriate referrals for a definitive diagnosis can be made. Currently there is no
screening tool used in pediatric dentistry for diagnosing OSA during the pre-operative
appointment or consultation for patients undergoing minimal and moderate oral conscious
sedation.
The purpose of the study was to develop a concise and easy-to-use questionnaire as a
screening tool to aid in the diagnosis of OSA in pediatric patients.

5

Materials and Methods

This project was approved under exempt status from the Virginia Commonwealth University
Institutional Review Board (VCU IRB #: HM15027).
This was a retrospective chart review of data previously collected as part of a routine
screening exam for patients referred for a sleep study. The original data was collected at the
VCU Center for Sleep Medicine for patients who presented from February 1st 2011 to February
1st, 2013, with no previous sleep disorder diagnosis. Study data were collected and managed
using REDCap electronic data capture tools hosted at Virginia Commonwealth University.
REDCap (Research Electronic Data) is a secure, web-based application designed to support data
capture for research studies.24 Prior to data collection, an excel file was created at the VCU
Center for Sleep Medicine and included all patients under the age of 18 who had completed a
polysomnography and thus had a definitive sleep disorder diagnosis. The excel file listed the
following information for each patient: patient name, medical record number, age at the time of
the study, and date of the polysomnogram.
In order to be included in the study patients must have met the following criteria:


Age < 18



Completed polysomnography with sleep disorder diagnosis



Sleep Questionnaire completed and scanned into chart
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Approximately 180 patients completed a polysomnography within the above time frame
and were listed in the excel file. Using this listing of patients, data was gathered from 2 sources:
Cerner, the Medical College of Virginia (MCV) electronic medical record, and the Sleep Center
database. Paper charts for all patients prior to 2011 were currently inaccessible, so only 180
charts were utilized in this study. A data collection sheet was fabricated to document each
variable needed in this study (Appendix 1). No patient identifiers were collected or used during
this study. The following variables were collected for this study: age of patient at time of PSG,
gender, race, height, weight, body mass index, presence of snoring, presence of tonsillar
hypertrophy, obstruction while sleeping, presence of neurobehavioral symptoms, daytime
tiredness or irritability, presence of neuromuscular disorders, presence of genetic disorders, the
patient’s Epworth scale score, and Apnea-Hypopnea index (AHI). The methods for determining
each are given below.
Date of PSG
The date of the polysomnogram was recorded from the excel file after being verified on Cerner.
Age
Age at time of sleep disorder diagnosis was calculated using the electronic Cornell University
age calculator (http://www-users.med.cornell.edu/~spon/picu/calc/agecalc.htm) in which the date
of birth and date of polysomnography are entered to compute a patient’s age in years and
months. Partial months were rounded down to whole numbers. As a risk factor, ages younger
than 3 or older than 12 years were coded as “yes”.
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Gender and race
Race (when specified) was recorded as Caucasian, African American, Asian, Hispanic, or written
in under “Other”. Gender was also recorded. Information on both of these variables was accessed
under Patient Demographics in Cerner.
Height, weight, body mass index
If not provided in the chart, body mass index was calculated using the Centers for Disease
Control and Prevention (CDC) BMI calculator for children and teens
(http://apps.nccd.cdc.gov/dnpabmi/). The calculator computes BMI and the “BMI-for-age”
percentile using the patient’s gender, age at time of measurement, height and weight. BMI-forage percentiles greater than 95% are coded as risk factor “Yes”.
Presence of tonsillar hypertrophy
This characteristic was coded as “Yes” when tonsillar hypertrophy was noted in the neurologist’s
preoperative note. Many patients who were being screened for OSA had recently seen an
otolaryngologist for tonsil evaluation. Preoperative notes were reviewed and tonsils recorded as a
3+ or 4+ were marked “yes” for tonsillar hypertrophy. If a patient had a tonsillectomy, or if it
was noted that the patient had tonsils 2+ or smaller, then tonsillar hypertrophy was marked as a
“No”. “Unknown” was recorded when tonsils were not mentioned on any neurologist or
otolaryngologist record during the time frame of the OSA screening.
Presence of neurobehavioral symptoms
Daytime neurobehavioral symptoms encompass attention deficit disorder with hyperactivity
(ADHD), attention deficit disorder without mention of hyperactivity (ADD), and oppositional
defiant disorder (ODD). These diagnoses were noted in the diagnosis section or at the top of the
polysomnogram under patient’s history. For example, the top of a typical polysomnogram report
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may read: “History: This 8 year-old female with a history of ADHD, Kabuki syndrome is being
evaluated for obstructive sleep apnea contributing to daytime fatigue and hypersomnolence and
loud snoring.” To verify these diagnoses the patient’s “Diagnoses and Problems” section was
reviewed in Cerner. If no disorder was mentioned in these two sections or in the other sleep
medicine documents, than the patient was recorded as not having any neurobehavioral
symptoms.
Presence of neuromuscular disorders
This characteristic was coded as “Yes” when a neuromuscular disorder was recorded under the
patient’s “Diagnosis” or if it was documented at the top of the polysomnogram report under
patient’s history. “No” neuromuscular disorder was recorded when it was not mentioned in any
of the above.
Presence of genetic disorders
This characteristic was coded as “Yes” when a genetic or congenital disorder was recorded under
the patient’s “Diagnosis” or if it was found documented at the top of the polysomnogram report
under patient’s history. “No” genetic or congenital disorder was recorded when it was not
mentioned in any of the above.
Sleep Study Questionnaire
Prior to undergoing a sleep study, each patient along with their parent would complete a sleep
questionnaire called “The VCU Center for Sleep Medicine: New Patient Questionnaire”
(Appendix 2). This five page document consisting of the Sleep-50 Questionnaire, gave each
patient the opportunity to complete the Epworth Scale, give a detailed medical history, and
respond to specific statements about a patient’s sleep hygiene25. Patients were asked to rate to
what extent a statement was applicable to them by circling 1, 2, 3, or 4. The number one
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corresponded to “Not at all”, 2 indicated “somewhat”, 3 “rather much” and 4 “very much”. The
prefabricated data sheet asked data collectors to determine whether the patient believed they
snored, had sleep obstruction, or was excessively tired or irritable during the day. Data collectors
recorded “Yes”, “No” or “unknown” to these variables. If the patient had circled 3 or 4
corresponding to a statement than that was considered a positive (yes) for whether the patient
had the symptom specific to that statement. A 1 or 2 indicated a negative response for the
symptom. The following variables below utilized the Sleep Study Questionnaire.
Presence of snoring
This characteristic was recorded solely based on the patient reporting symptoms and not on
whether the patient snored during the polysomnography. Snoring was coded as “Yes” when
snoring was noted on patient’s referral form, noted in the neurologist’s preoperative notes, or
when the parent and patient recorded a “3” or “4” when responding to the question “I am told
that I snore”. In the sleep questionnaire “1” corresponds to Not at all, a “2” simulates
“somewhat”, a “3” denotes rather much while “4” means very much that the patient has certain
symptoms. “No” was recorded when a patient selected 1 or 2 when responding to the question “I
am told that I snore”, or when the neurologist had noted that the patient did not snore.
“Unknown” was recorded when snoring was not mentioned in the doctor’s preoperative note, the
referral form, or when the sleep questionnaire was not completed.
Obstruction while sleeping
This characteristic was recorded based on the patient’s symptoms. Sleep obstruction was coded
as “Yes” when sleep obstruction was noted on the patient’s referral form, noted in the
neurologist’s preoperative notes, or when the parent and patient recorded a “3” or “4” when
responding to the questions: “I am told that I hold my breath when sleeping” and “I am told that I
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wake up gasping for air”. “No” was recorded when a patient selected 1 or 2 when responding to
the same questions, or when the neurologist had noted no past history of obstruction. Unknown
was recorded when sleep obstruction was not mentioned in the doctor’s preoperative note, the
referral form, or when the sleep questionnaire was not completed.
Daytime tiredness or irritability
This characteristic was coded as “Yes” when the patient recorded a “3” or “4” when responding
to the majority of the following questions: “I feel tired at getting up”, “I feel sleepy during the
day and struggle to remain alert”, “I would like to have more energy during the day”, “I am told
that I am easily irritated”, or “I have difficulty in concentrating at work or school”. No was
recorded when the patient had marked a “1” or “2” to a majority of these questions. Unknown
was recorded if the sleep questionnaire had not been completed.
Apnea-Hypopnea index (AHI)
As previously mentioned, OSA is primarily diagnosed by a patient’s apnea-hypopnea index
(AHI). The AHI represents the average number of apneas and hypopneas per hour of sleep10 and
was obtained from each polysomnogram. In children, more than one obstructive apnea event of
any length per hour of sleep is considered abnormal.26,27 Based on these recommendations, in
this study mild AHI was defined as >1.5, moderate >5 and severe >15. For the purposes of
analysis, AHI was categorized two ways. One categorization characterized apnea as: none (AHI
≤ 1.5), mild (AHI > 1.5), moderate (AHI > 5), or severe (AHI > 15). The primary categorization
was a binary outcome: apnea negative (AHI ≤ 5) or apnea positive (AHI > 5).
S(T1)OPBANG
There were two scales evaluated, differing only in the “T” variable. S(T1)OPBANG was the sum
of the presence of snoring (S), tonsillar hypertrophy (T1), observed obstruction (O), neuro-
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psych-behavioral symptoms such as ADHD or daytime irritability (P), BMI percentile for age
(B), age at diagnostic screening (A), presence of neuromuscular disorder (N), and presence of
genetic/congenital disorder (G). Yes values were scored as 1 and all other values (No and
unknown) were scored as zero in the calculation of the sum.
S(T2)OPBANG
The S(T2)OPBANG score was calculated as above but tiredness evaluated through the Epworth
scale; pESS>10. (T2) replaced tonsillar hypertrophy.
Purpose
The primary aims of the study were to test two scales for the identification of sleep apnea in
children. The secondary aims were to test each of the components of the sleep apnea scale.
Data analysis
All the information from the data sheets was entered into a REDCap database for analysis. A
second party for input errors checked all information entered. All analyses were performed using
SAS software by the project biostatistician, Dr. Best. All of the patients were described
according to the STARD standard for reporting diagnostic accuracy.28 This includes complete
reporting of patients excluded from study. The statistical methods included screening of each
diagnostics characteristic (using chi-square analysis) and a multiple logistic regression analysis
of the OSA diagnosis to determine which diagnostics characteristics are associated with the
diagnosis. Final reporting included odds-ratios and 95% confidence intervals on all estimates.
Using the projected 250 charts that were initially thought to be available, and estimating the
prevalence OSA of at least 25% and odds-ratios of at least 2, the study had approximately 80%
power (at alpha=0.5).
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Results

There are three major sections included in the Results: The first section is a description of the
results of the process from the identification of potential subjects to the building of the final
analysis dataset, and a description of the subjects analyzed. The second section includes the
testing of the primary aims. The third section denotes the exploration of each of the components
and the proposal of a revised scale.
Data gathering and Description of subjects
The sleep study questionnaire was completed on paper and scanned into the patient’s chart in
Cerner. Occasionally sleep study questionnaires were not scanned into Cerner or parents and
patients did not complete the sleep study questionnaire in its entirety. If the variables were
unable to be collected that particular patient was excluded from the study. Often this information
was gleaned from a direct referral form previously completed by a primary care physician or a
specialist such as an Otolaryngologist. The referring doctor would complete the Patient History
section, in which they could check such parameters as excessive daytime sleepiness, loud
snoring, neuromuscular disease, obesity, observed apneas, wakes with choking/gasping.
Referring doctors could also write in other diagnoses that were not listed. This direct referral
form was used in lieu of a sleep questionnaire if all parameters were answered and if it was
evident the patient was nonverbal and could not complete the sleep questionnaire. Otherwise the
patient was excluded due to lack of information. A total of 153 subjects with usable data were
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analyzed. 54% were male and the predominant race groups were whites (45%) and blacks (43%,
See Table 1). Neither gender (P = 0.4455) nor race (P = 0.1368) appeared related to the AHI
scores. Subjects ranged in age from 38 months to 17.5 years (mean = 10.6, SD = 4.1). Subjects
ranged in height from less than a meter (3 feet) to 1.88M tall (6 foot 2 inches). One height was
not available for a subject. Subjects ranged in weight from 12.7kg (28 pounds) to 189kg (416
pounds). Height was roughly normally distributed, but weight was skewed, as is indicated by the
fact that the median weight (42kg) was considerably lower than the mean weight (50kg). BMI
2

was calculated from height and weight and averaged 23.32kg/m (SD = 8.9). Since the amount of
body fat changes with age and differs between boys and girls, the BMI-for-age percentiles are
used for comparisons. BMI-for-age is strongly skewed with a large number of percentiles at 95%
or above. There were 60 subjects (39%) who were described as obese since they were above the
95th percentile for age and gender. Another 27 subjects (18%) were overweight (between the 85th
and 95th percentile). Only 54 subjects (36%) had what is considered a healthy weight (between
the 5th and 85th percentile); 11 subjects were underweight (7%).
Scales
There were two scales tested in this study and the components for each are summarized in Table
2. Over 59% of all subjects had a positive indication in the medical record for snoring (n = 91)
but 11 subjects lacked any reference in the record regarding snoring (7%). For the purposes of
the scale score, a “yes” was counted as positive and both “no” and “unknown” were not counted
as positive (and so they are effectively counted as negative). Thus the prevalence of each of these
components ranged from a high of 59% (snoring) to a low of 14% for both neuromuscular
disorders and for genetic/congenital disorders.
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Note that for the purposes of the scales, daytime neurobehavioral symptoms and
excessive tiredness during daytime were combined such that if either was a “yes,” the
combination was scored as a positive. There were 13 “yes” for both, 13 “yes” on daytime
neurobehavioral symptoms only, and 66 “yes” on excessive tiredness. And so there were 92
yeses on this combined indication (60%), 60 no (39%), and only 1 unknown (1%).
The primary outcome variable was observed apneas and hypopneas, as indicated by AHI.
The raw AHI values ranged from 0 to 85.7, with a median value of 0.8. The strongly skewed
values yielded a mean of 4.08 (SD = 9.53). Table 3 indicates that 82% (96=none, and 29=mild)
were considered negative for apnea and therefore that 18% (16 moderate and 12 severe) were
considered positive.
For the S(T1)OPBANG scale (snoring, tonsillar hypertrophy, sleep obstruction, daytime
neurobehavioral symptoms/tiredness, BMI, age, neuromuscular and genetic), the scores ranged
from 0 to 6 (Mean = 2.76, SD = 1.34) and for the S(T2)OPBANG scale (snoring, Epworth, sleep
obstruction, daytime neurobehavioral symptoms/tiredness, BMI, age, neuromuscular, and
genetic), the scores ranged from 0 to 6 (Mean = 2.84, SD = 1.42, see Table 4). Since they share
components, it is not surprising that the two scores are strongly correlated (r = 0.90, P < .0001).
Logistic regression was used to test for a relationship between the S(T1)OPBANG scale
and apnea. There was a statistically significant relationship (likelihood ratio chi-square = 11.5, P
= 0.0007). Table 5 shows the relationship between each scale value and the sensitivity and
specificity. For instance, if S(T1)OPBANG≥6 is used as a cutoff, then 2 subjects are predicted to
be positive. Of the 28 actual positives one has a cutoff 6 or greater and so the sensitivity is 4%
(1/28). Of the 125 actual negatives, all but one has a cutoff below 6 and so the specificity is 99%
(124/125). As the cutoff decreases, sensitivity must go up and specificity must go down. If the
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risk of false positives and false negatives were equal, then the cutoff yielding the largest
sensitivity + specificity would be the optimal cutoff. In the case of S(T1)OPBANG, this cutoff is
4 (sensitivity=57%, specificity=78%).
For the S(T2)OPBANG scale there was also a statistically significant relationship
(likelihood ratio chi-square = 8.27, P = 0.0040). Table 6 shows the relationship between the
sensitivity and specificity and each scale value. In the case of S(T2)OPBANG, the cutoff
yielding the largest sensitivity + specificity is 5 (sensitivity =36%, specificity = 90%).
One way to determine which of the two scales might be preferred is to use both as
predictors in a multiple logistic regression. This indicates that when S(T1)OPBANG is used as a
predictor, S(T2)OPBANG provides no additional predictive value (P = 0.70). Conversely, if
S(T2)OPBANG is used as a predictor, then S(T1)OPBANG provides some additional predictive
value (P = 0.0644).
Analysis of the components
Each of the individual components was first screened using a chi-square test (Table 7). The
results indicate that the only statistically significant risk factor was sleep obstruction (P=0.001).
However all components had a relative risk value greater than 1 except for neuropsychbehavioral symptoms/tiredness (RR=0.77). A multiple logistic regression analysis was used to
test the significance of each of the components of the scales and shows the results for the
components of S(T1)OPBANG (Table 8). Although the test that all eight components provided
predictive value was significant (P = 0.0024), only one component was individually significant.
The presence of an obstruction was positively related to apnea (P = 0.0010). Most of the other
components had an odds-ratio larger than one (indicating a nominally positive relationship).
However, two components—snoring and neurobehavioral symptoms/daytime tiredness had odds
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ratios below one, which indicates that the presence of the component is negatively related to
apnea. Similar results were found for the components of S(T2)OPBANG (Table 9). That is,
although 23% of those who snore were OSA positive and 11% of those who did not snore
(RR=2.04), after all of the other risk factors were taken into account, snoring was not a
significant predictor of OSA (OR=0.74, P>0.6). Similarly 26% of children with tonsillar
hypertrophy had OSA and16% of those who did not (RR=1.57). But tonsillar hypertrophy was
not significant after others were accounted for (OR=1.96, P>0.2). There was no evidence that an
Epworth score greater than 10 was related to OSA since those who were above the cutoff had
19% OSA, as compared to 18% of those below the cutoff. On the other hand of those with a
sleep obstruction 34% were positive for OSA and only 9% of those without a sleep obstruction
were positive to OSA (RR=3.98). This remained a significant predictor of OSA (OR=7.56,
P=0.0010). Being positive for either neurobehavioral daytime symptoms or excessive daytime
tiredness/irritability was actually nominally protective against OSA since there were fewer OSA
case in those who were positive than in those who were negative (16% vs 215). Obese children
were OSA positive 25% of the time and non-obese children 14% (RR=1.79) but the adjusted
analysis did not indicate that it was a significant predictor (OR=1.90, P>0.2). Those in the age
risk categories were OSA positive 23% of the time whereas those who were in the middle ages
were positive 16% of the time (RR=1.42) but age was not statistically significant in the adjusted
analysis (OR=2.42, P=0.1004). This result is suggestive, however. Those with neuromuscular
diagnoses were as likely to be OSA positive than those without these diagnoses (19% vs 18) and
the adjusted analysis also did not support a significant relationship (OR=3.06, P=0.1482). Again,
this is a suggestive result. And those with genetic/congenital defects were more likely to be OSA
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positive than those without these conditions (24% vs 17%, RR=1.37). Moreover, the adjusted
analysis advocate some potential for a relationship (OR=3.71, P=0.0648).
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Discussion

In this retrospective chart review, specific variables were compared with AHI scores in order to
develop a screening tool with a high sensitivity and also a high specificity for pediatric
obstructive sleep apnea. Less than half of children with OSA symptoms actually have the
syndrome.29 As a result screening for OSA is very complicated and causes many children to go
undiagnosed. Presently, pediatric OSA is under diagnosed and as a result undertreated because of
the high cost to test for OSA and the limited number of pediatric sleep laboratories.
Consequently screening for OSA has become essential.30 A recently published systematic review
and meta-analysis by Canto et al (2014) explores the diagnostic value of alternative methods
such as clinical history and physical examination to identify pediatric OSA, and also validates
the role dentists play in screening patients.31 In the following discussion, the findings of the
current study will be compared to the results of Canto’s systematic review where applicable. The
results of the current study found a clinically significant correlation between each proposed scale
and AHI, however only one individual component was strongly related to AHI. Suggesting that
certain variables that present together in a single individual may predispose that person to OSA,
more so than individual parameters. Below each variable evaluated in this study is dissected
along with present findings and suggestions for a revised screening tool based on these results.
In a review on sleep disordered breathing in children, Padmanabhan et al. ascertained that
snoring, apnea, and difficulty in breathing were the three main symptoms of OSA in children and
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infants. Snoring occurs in almost all children with a sleep disorder; often it is the catalyst for
parents to believe there is a problem and to pursue a medical consult.32 Parents who hear their
children snore perceive them struggling to breathe and often are anxious about their nighttime
breathing habits.10 Furthermore, snoring remains the most common complaint in sleepdisordered breathing for children under five years old.26 Interestingly enough, only a fraction of
children who snore have OSA,32,33 and the presence of snoring alone cannot accurately predict
OSA.10 Habitual snoring is a hallmark of sleep-disordered breathing and denotes loud snoring at
least three nights per week.34 A great number of children who habitually snore have primary
snoring, which is habitual snoring without changes in ventilation or oxygenation.30 The
correlation between snoring and AHI in our study overall had a very weak relationship both
individually (P=0.0642) and once all values were adjusted for every component (P=0.6767).
These results reflect our sample of patients as all subjects presented to the sleep center citing
sleep difficulty. Our study suggests a correlation that is not necessarily predictive, reinforcing the
idea that the presence of snoring does not automatically ascertain that the child has OSA.10
Young et al determined 10-14% of children snore every night or every other night, and found a
prevalence of OSA in 10 to 20% of habitual snorers.35 Our results are similar- 21 out of 91
subjects who reported snoring exhibited moderate or severe OSA. Canto et al evaluated three
snoring characteristics and reported the sensitivity and specificity of each: snoring disturbs others
(sensitivity = 68% and specificity = 58%), snoring every night (sensitivity = 91% and specificity
= 75%) and snoring extremely loudly (sensitivity = 52% and specificity = 78%). Snoring every
night had the highest sensitivity with fair specificity.31 Unfortunately snoring was not quantified
in this retrospective chart review, and so parents may have reported their child snored even when
it was infrequent. Moreover, our study was limited in that data relied on reporting of parents who
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likely have varying subjective standards for what they consider “snoring” and also vary in their
opportunity to observe the behavior. Snoring alone is not a sensitive indicator of OSA, but
because it is a prevalent symptom of OSA it remains a useful variable in our screening tool.
As mentioned above, sleep obstruction is another common symptom of children with
OSA and represented the O in our study. Obstructive apnea occurs when there is respiratory
effort and lack of airflow.36 In adults obstructive events need to be at least 10 seconds long in
order to be scored. However, in children the obstructive events need to occur over 2 breaths or
more.4 A different standard is necessary as children have a faster respiratory rate and lower
functional residual capacity. Moreover, shorter respiratory events in children have more
physiological consequences.10 Our results exemplified a strong ordinal relationship with AHI and
obstruction (P=0.0010), with a sensitivity of 71% and a specificity of 69%. It is surmised that
there is a strong correlation for two reasons, first the obstruction that parents report most likely
represent the apnea and hypopnea events significant for OSA, and second, choking and gasping
during sleep is a very distinct sound that may be definitively distinguished from that of snoring.
Consequently while other symptoms reported by parents may not always be accurate, it is
difficult to misinterpret pauses in breathing exemplified by “choking and gasping sounds”. In
Canto et al, evaluation of whether pauses in breathing were diagnostic were not as definitive.
Observable apnea only showed a sensitivity = 36% with a strong specificity = 95%. Observed
obstructive apneas had almost equal sensitivity and specificity, with 61 and 65%, respectively.31
In this study obstruction represents the variable with the strongest correlation to AHI and thus
remains in our revised screening tool.
For the T component of our modified STOPBANG we utilized two different variablestonsillar hypertrophy and tiredness reflected through the value of the Epworth scale. Neither of
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these variables showed a significant correlation with AHI in this study (P=0.2449 and P=0.4831,
respectively). Presently the most common identified risk factor in childhood OSA is
adenotonsillar hypertrophy.2,37,38 Lingual and pharyngeal tonsils can be visualized intraorally
whereas adenoids cannot. Tonsillar size can range from Type 0 where the tonsils are absent to
Type IV where the right and left tonsillar tissue approaches the midline. Based on Scammon’s
growth curve, lymphatic tissue begins to shrink after the age of six but the presence of large
tonsillar and adenoid tissue may negate this normal reduction and obstruction may persist.8 The
primary treatment for OSA in children is adenotonsillectomy.2,37,38 Removal of the adenoids and
tonsils relieves crowding in the airway and permits air to flow more freely through the nasal and
oral passages.2 In The Childhood Adenotonsillectomy Trial (CHAT) by Marcus et al., watchful
waiting was compared to the outcomes of removing the tonsils in school-age children. This study
found that patient’s symptoms overall improved as well as quality of life and polysomnography
findings. However surgical treatment did not improve attention or function evaluated through
neuropsychological testing.37 Like snoring, the presence of large tonsils does not automatically
give the patient OSA. Several studies have reported that no relationship exists between the size
of the tonsil and adenoids and the presence of OSA.10,39,40 Canto et al systematic review found
overall weak results concerning tonsils: with sensitivity = 69% and specificity = 53% for
tonsillar hypertrophy and sensitivity = 81% and specificity = 58% for Grade 3 tonsil size.31
There was not a significant correlation in our study to size of tonsils and AHI (P=0.2449).
However this study was limited in that tonsillar hypertrophy was not routinely recorded. If the
patient did not have a direct referral there would be an initial visit where size of tonsils was often
noted. Frequently patients would also seek out an otolaryngologist around the same time frame
where the size of the tonsils was noted. Tonsillar size was gleaned from these two documents. A
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little less than half (72 out of 153) of the subjects’ tonsil size was unable to be reported. These
unknowns were recorded as “no” in the data analysis. These limitations likely cause the data in
this study to underreport tonsillar hypertrophy. Despite these results and the lack of literature
ascertaining tonsillar hypertrophy to predict OSA, it continues to a major cause of OSA2 and
consequently will remain in the revised screening tool.
The Epworth Sleepiness Scale (ESS) measures a person’s general level of daytime
sleepiness. It contains 8 questions that explore a person’s propensity to fall asleep during the day.
Scores range from 0 to 24. In adults, a score of greater than 10 suggests heightened daytime
sleepiness. In a study by Melendres et al., researchers modified the ESS to be more applicable to
children. The suggestion of alcohol was deleted in question 7 and driving a car in question 8 was
changed to being a passenger in a car. Melendres’ study found that the ESS score of patients with
OSA was not statistically different from those with primary snoring. Their results did not
illustrate a difference between the ESS score of patients with mild, moderate, and severe OSA.41
These results are similar to those in the present study where the ESS had no relationship to AHI
(P = 0.4831). Parents and patients were asked to complete a typical 8 question ESS that was not
modified for children (Appendix 3). Scores above 10 signified excessive sleepiness. These
results, similar to the Melendres study, suggest that ESS holds little value in predicting OSAS
and will be omitted in the revised screening scale.
The P in our modified STOPBANG screening tool represents neuropsych-behavioral
symptoms in which excessive tiredness and irritability during the daytime was combined with
daytime neurobehavioral symptoms. Positive scores of neurobehavioral symptoms required a
diagnosis from a medical professional of either attention deficit disorder with hyperactivity
(ADHD), attention deficit disorder without mention of hyperactivity (ADD) or oppositional
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defiant disorder (ODD). This variable was analyzed because daytime hyperactivity and
inattention have been shown to be associated with restless sleep. Moreover, improved sleep
patterns have led to positive changes in behavior.23,42,43 Sleep fragmentation, which is prevalent
in pediatric OSA, may result in impaired daytime functioning.23,44,45 Relationships between OSA,
hyperactivity, and inattentive behavior have been documented.23,46-51 Yet excessive tiredness,
irritability, and hyperactivity are widely prevalent in children without OSA.23,41,52-56 Unlike
adults, children do not have the degree of daytime tiredness with sleep disordered breathing
because their nighttime obstructive spells are more transitory and the periods of arousal are less
discernable.32 The occurrence of excessive daytime sleepiness in children with OSA is vague as
it depends on the perception of the parents or caretakers. Young children most likely will not
report tiredness.23 In this retrospective chart review, parents completed the sleep questionnaire
for the majority of subjects under the age of 12, their answers seemingly subjective and naturally
influenced by their own thoughts, feelings, and attitudes on tiredness and their child’s irritability.
The results of this study indicated no relationship to AHI score and the reporting of excessive
tiredness/irritability (P=0.3191). This study found that higher AHI scores were apparent in those
with neurobehavioral daytime symptoms however it was not significant. Literature on
neurobehavioral symptoms exemplifies a wide range of results. In a study by O’Brien et al., 26%
of children with mild symptoms of ADHD were shown to have OSA via a polysomnograph.14,57
A more recent study found that in children 6 to 14 years old with ADHD, OSA was not a
common underlying disorder or etiologic factor.14,58 Yet there is evidence to show persistent
sleep disturbance can affect cognition, mood, behavior, and family function.14,59 As mentioned
previously, the CHAT study conducted by Marcus et al. ascertained that surgical treatment for
OSA in school-age children, while improving symptoms and quality of life, did not improve
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attention or executive function.37 Canto’s review showed attention deficit/hyperactivity disorder
to have a sensitivity = 52% and a specificity = 67%, not an overall strong correlation.31 Based on
the lack of evidence that psycho-behavioral symptoms and reports of tiredness/irritability have
significant predictive value, this variable will be omitted in the revised scale.
The B in this retrospective chart review denotes body mass index (BMI) percentile for a
given age. Due to varying changes in height and weight during a child’s growth and
development, BMI percentiles specific for age and sex are the best way to depict childhood
weight status. BMI > 95% indicates an obese child. BMI > 85-94% represents children who are
overweight. Underweight children are in the BMI < 5% category.60 It was proposed that BMI
percentiles above 95% would place a patient at risk for OSA. Obesity has been found to
predispose patients to OSA due to the mass loading of upper airway and respiratory muscles, in
addition to impairment of ventilation. OSA in obese children ranges from 13 to 36%, based on
the severity of obesity.61,62 A review of the scatterplot (Figure 4) indicates that in this study not
only are patients above the 85th percentile at risk for OSA, but also patients below the 10th
percentile for BMI. These differences in BMI appear to account for the two types of pediatric
OSA: Type I: non obese with adenotonsillar hypertrophy and Type II: obese with mild upper
airway lymphadenoid hyperplasia23 that were proposed earlier. With obesity on the rise, it is easy
to forget that traditionally, OSA children were non-obese.63,64 Case series have suggested that
growth (especially weight gain) accelerates after surgery for OSA, proposing that OSA may
inhibit growth.65-68 These results agree with the findings in this study, that not only are
overweight and obese children predisposed to OSA, but underweight children may also indicate
OSA. Furthermore, BMI percentiles >85% and <10% appear to be a risk factor for OSA and
these parameters will reside in the revised screening tool.
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In our study age presents the A in STOPBANG and was defined as a risk factor for
patients younger than 3 or older than thirteen. Evidence of systematic variability with age in
pediatric OSA is lacking.69 Pediatric OSA can occur at any age from birth to adolescence,
however it is most common in the preschool age according to the International Classification of
Sleep Disorders Diagnostic and Coding Manual.12 It has been reported that the peak incidence of
OSA is between 2 and 6 years of age,9 while other studies cite a high prevalence around 2-8
years with a subsequent decline in frequency.70 Our original age parameters are based on the
theory that children younger than 3 may have underdeveloped airways and patients older than 13
are nearing their full growth potential and may start to develop adult risk factors for OSA such as
obesity and high blood pressure. After analysis of the data, a reconsideration of age cutoffs is
proposed, as it appears in this study that children younger than 4 and older than 16 are at most
risk for OSA, yielding specificity as high as 88% and sensitivity as high as 61% (Figure 4). Thus
these changes are taken into account in our revised scale.
The N in the modified STOPBANG screening tool represents neuromuscular disorders.
Neuromuscular disorders related to abnormalities of muscle tone, hypotonia, and spasticity
influence a child to have OSA.9 The results of this study show a weakly positive relationship to
AHI (P=0.1482). This study was limited in that there was a very low sample size of patients who
had a neuromuscular disorder- only 21 patients out of 153. This low sample size may have
prevented a predictive value with AHI. Some of the neuromuscular disorders of subjects in this
study were muscular dystrophy and cerebral palsy. Neuromuscular deficits, along with
craniofacial abnormalities and soft tissue hypertrophy, are frequently the origin of airway
narrowing.69 Patency of the upper airway is a reflection of the muscle activities. In
neuromuscular disorders the decrease in muscle tone can greatly alter the airway. In disorders
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such as duchenne muscular dystrophy and cerebral palsy, the presence of sleep disordered
breathing arises because the weakened dilator and respiratory muscles are further weakened
during sleep.61 Although neuromuscular disorders did not show a strong correlation to AHI in
this study, it remains in the revised scale as it is cited as one of the main causes of OSA.32,35
The G in the modified STOPBANG represents genetic disorders and congenital disorders
and like neuromuscular disorders, did not show a strong correlation to AHI in the current study
(P=0.0648). Many of these disorders are the underlying etiology of upper airway obstruction as a
result of craniofacial malformation.71,72 A wide range of these disorders results in variable
expression in each patient with individualized respiratory compromise. Most often congenital
disorders may result in the mandible failing to grow in utero.71,72 Children with Down syndrome
fall into the genetic disorder category and it has been shown that 31 to 45% of Down syndrome
children are affected by OSA because of characteristics such as midfacial hypoplasia,
micrognathia, and muscular hypotonia that reduce the size of the upper airway.61,73 Other
syndromes with craniofacial abnormalities such as Apert’s and Crouzon’s have been shown to be
disposed to OSA.61,74 In the systematic review and meta-analysis by Canto
micrognathia/retrognathia had a sensitivity=0% with a specificity=95%. Furthermore, midface
hypoplasia overall had a sensitivity = 16% and a specificity = 100%.31 These results ascertain
that craniofacial anomalies are not highly predictive of pediatric OSA. Like neuromuscular
disorder patients, in our study there was a very small sample size from the data collected- only
21 out of 153 subjects had a genetic/congenital disorder. We propose to keep genetic/congenital
disorders in the screening tool as craniofacial anomalies and syndromes were ascertained to be a
cause of OSA.32
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If the 7 revised components mentioned above were used to score the likelihood of OSA, a
multiple logistic regression indicates that more components would have been statistically
significant (see Table 10). Even though the p-values in the table are not entirely fair, as they are
the result of post-hoc data mining, it does suggest that the additional factors of BMI risk, age
risk, and instances of neuromuscular disorders or genetic/congenital disorders may be important
indicators of higher OSA risk. Unfortunately, as snoring was measured in this study, this analysis
did not give any statistical support for its continued inclusion.
There were several limitations in this retrospective chart review. The collection of data
from the sleep questionnaire proved challenging because several questions pertained to the
presence of a single variable and answers were varied. For instance, patients and parents had to
answer several questions detailing the patient’s tiredness throughout the day. Often times some
of the questions would be answered denying the symptom and several more ascertaining the
presence of the symptom. The majority was recorded, but since several questions represented
one variable this could have skewed the results. Much of the information collected was limited to
the parents. Many of the completed sleep questionnaires had inconsistent answers recorded. For
instance, the patient would have a very low ESS value but parents would indicate that the patient
did indeed have excessive sleepiness during the daytime in the actual questionnaire. There
remained a lack of verification from the parents reporting and it was not clear whether the patient
or parent had filled out the questionnaire. Expectation bias most certainly may have existed in
this study as the Examiner was recording the PSG results and also the presence of specific
variables that suggest OSA. In an attempt to avoid expectation bias, when able, variables were
recorded first on the data sheet prior to accessing the PSG results. Since data was collected
routinely prior to this study, often variables were not recorded and information was missing, this
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restricted the amount of subjects able to be used. Prior to 2011, all sleep questionnaires and
patient information was recorded in paper charts. These charts were unable to be accessed at the
time of data collection; as a result the sample size was less than originally projected. The sample
size does not represent an average population of children as all patients were believed to have a
sleep disorder problem and as a result were seeking a diagnosis; thus this study may contain
selection bias. It is possible that patients were unable to replicate their natural sleep during the
polysomnography and did indeed have OSA. Patients whose ages ranged from 0–18 were
included in the data collection. Patients over a certain age (12–14) often are almost fully grown
and considered adults, consequently variables in the older age range could have skewed
characteristics specific for children. Lastly, because this study was retrospective, researchers
were limited in what variables could be used in the screening tool as to what information had
been previously collected. For instance, tonsillar hypertrophy was considered as an important
screening tool but had not always been recorded by the clinician.
There were several variables that this study did not focus on but may be relevant to
pediatric OSA. It has been frequently mentioned that there is a genetic component to children
with OSA. Future studies may want to include evaluation of whether the parents or siblings
currently have a sleep disorder. The siblings of children who have been treated for sleep
disorders are more likely have sleep disordered breathing.11,75 In addition, children with a family
history of OSA are four times more likely to have OSA compared to children from families with
no OSA diagnosis.76,77 It is also recommended to define snoring both quantitatively and
qualitatively to omit those children whose snoring is infrequent and not really suggestive of
OSA. Mouth breathing during the daytime (sensitivity = 26%, specificity = 79%) and during
sleep (sensitivity = 68%, specificity = 42%) was evaluated for diagnostic quality in a previous
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study31. Despite the mediocre results, mouth breathing is easily diagnosed by dentists and may be
a variable useful for screening patients. Ethnicity may also play a role in screening at risk
pediatric patients for OSA. Literature cites that being African American is a risk factor,14,78-80
however this was not found in our study. Kheirandish-Gozal et al. found that the prevalence of
OSA was increased in poorly controlled asthmatic children;70 perhaps this variable should be
included in future studies. Worthy of attention would be a prospective study in which variables
typical of Pediatric OSA and commonly diagnosed clinically by dentists could be evaluated to
determine a predictive value. Further evaluation is recommended to continue to strive and find a
highly predictive screening tool for pediatric OSA.
Polysomnography studies have proven labor intensive and have shown to be inaccessive
to children. Moreover Gozal ascertains that “development of simple, cheap, and reliable
diagnostic tools that permit more expanded screening of at-risk populations, and enable accurate
identification of the children with definitive disease or with definitive absence of disease would
revolutionize the field and provide timely access to clinical care to a large sector of the pediatric
population, thereby reducing the health burden of OSA”.30 This study attempted to further clarify
which variables were strongly associated with childhood OSA, and thus could be used to develop
a screening tool that would accurately predict the disorder in at risk children.

30

Conclusions

The purpose of the study was to develop a concise and easy-to-use questionnaire as a screening
tool to aid in the diagnosis of OSA in pediatric patients. The screening scale proposed
(S(T1)OPBANG) proved to be predictive of pediatric OSA. Based on the results of this study
and the review of the literature the following components are recommended to remain in a
revised screening tool: presence of snoring, sleep obstruction, and tonsillar hypertrophy; BMI,
age, neuromuscular disorders and genetic/congenital disorders. Worthy of attention would be to
explore ethnicity factors, presence of asthma, and family history of OSA in future studies.
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Table 1. Demographic Characteristics of Study Subjects (N=153)
Characteristic
Gender
Female
Male
Race/ethnicity
Asian
Black or African American
Hispanic
White
Unknown / Not Reported

Age (years)
Age (months)
Height (M)
Weight (kg)

N Percent
70
83

45.8
54.2

4
66
5
69
9

2.6
43.1
3.3
45.1
5.9

Mean
10.59
127.06
1.40
49.56

SD Median
Range
4.10
10.50
3.17
17.50
49.21 126.00 38.00 210.00
0.24
1.42
0.91
1.88
31.13
42.18 12.70 188.70

2

BMI (kg/mm ) (n=152)
23.32
8.85
72.73
33.52
BMI percentile
Epworth scale (n=112)
8.57
6.29
Abbreviation: SD = standard deviation,

21.17 11.26
59.69
91.42
0.00 100.00
8.00
0.00
24.00
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Table 2. Risk Factors
Risk Factor
Snore

Tonsillar hypertrophy

Epworth > 10

Obstruction

Daytime neurobehavioral symptoms

Excessive tiredness/irritability during
daytime

Neuro/Muscular disorder

Genetic/Congenital disorder

BMI percent >= 95

Age < 3 or > 13

Risk
factor
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown

N
51
91
11
50
31
72
69
43
41
80
59
14
125
26
2

Percent
33.3
59.5
7.2
32.7
20.3
47.1
45.1
28.1
26.8
52.3
38.6
9.2
81.7
17.0
1.3

No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown
No
Yes
Unknown

57
79
17
0
21
132
0
21
132
92
60
1
105
48
0

37.3
51.6
11.1
0.0
13.7
86.3
0.0
13.7
86.3
60.1
39.2
0.7
68.6
31.4
0.0
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Table 3. Apnea-Hypopnea Index
Apnea-Hypopnea
index
0-none
1-mild
2-moderate
3-severe

N
96
29
16
12

Percent
62.75
18.95
10.46
7.84
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Table 4. Scales
Score
0
1
2
3
4
5
6

S(T1)OPBANG
N
Percent
2
1.3
28
18.3
39
25.5
40
26.1
25
16.3
17
11.1
2
1.3

S(T2)OPBANG
N
Percent
4
2.6
24
15.7
38
24.8
40
26.1
25
16.3
17
11.1
5
3.3
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Table 5. S(T1)OPBANG Scale Results
S(T1)OPBANG Specificity Sensitivity
.
100%
0%
6
99%
4%
5
94%
39%
4
78%
57%
3
48%
68%
2
21%
86%
1
2%
100%
0
0%
100%
0
0%
100%
Logistic regression P = 0.0007, AUC = 67.7%

True
Pos
0
1
11
16
19
24
28
28
28
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True
Neg
125
124
117
97
60
26
2
0
0

False
Pos
0
1
8
28
65
99
123
125
125

False
Neg
28
27
17
12
9
4
0
0
0

Table 6. S(T2)OPBANG Scale Results
S(T2)OPBANG Specificity Sensitivity
.
100%
0%
6
99%
14%
5
90%
36%
4
74%
50%
3
46%
68%
2
19%
86%
1
3%
100%
0
0%
100%
0
0%
100%
Logistic regression P = 0.0040, AUC = 64.3%

True
Pos
0
4
10
14
19
24
28
28
28
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True
Neg
125
124
113
92
57
24
4
0
0

False
Pos
0
1
12
33
68
101
121
125
125

False
Neg
28
24
18
14
9
4
0
0
0

Table 7. Unadjusted Analysis Results
Risk indicator
Snore

OSA
Negative Positive
No
55
7 11%
Yes
70 21 23%

Tonsillar hypertrophy No
Yes

RR p-value
2.04 0.0642

102 20 16%
23
8 26%

1.57

0.2262

Epworth > 10

No
Yes

90 20 18%
35
8 19%

1.02

0.9515

Sleep obstruction

No
Yes

86
8
9%
39 20 34%

3.98

0.0001

neuroPsych or tired

No
Yes

48 13 21%
77 15 16%

0.77

0.4329

BMI percent > 95

No
Yes

80 13 14%
45 15 25%

1.79

0.0852

Age < 3 or Age > 13

No
Yes

88 17 16%
37 11 23%

1.42

0.3181

Neuro/Muscular

No
Yes

108 24 18%
17
4 19%

1.05

0.9241

Genetic/Congenital

No
Yes

109 23 17%
16
5 24%

1.37

0.4821
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Table 8. Components of S(T1)OPBANG
Component
S Snore=yes
T Tonsillar hypertrophy=yes
O Obstruction=yes
Neurobehavioral=yes or
P Tiredness=yes
B BMI% > 95
A Age < 3 or Age > 13
N Neuromuscular=yes
G Genetic/congenital=yes
All 8 components

Chisquare
0.17
1.35
10.77

P-value
0.6767
0.2449
0.0010 *

OR
0.74
1.96
7.56

95% CI
0.19
2.99
0.63
6.05
2.26
25.27

0.99
1.30
2.70
2.09
3.41
23.84

0.3191
0.2551
0.1004
0.1482
0.0648
0.0024 *

0.61
1.90
2.42
3.06
3.71

0.24
0.63
0.84
0.67
0.92
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1.60
5.73
6.96
13.92
14.90

Table 9. Components of S(T2)OPBANG
Component
S Snore=yes
T Epworth
O Obstruction=yes
Neurobehavioral=yes or
P Tiredness=yes
B BMI% > 95
A Age < 3 or Age > 13
N Neuromuscular=yes
G Genetic/congenital=yes
All 8 components

Chisquare
0.04
0.49
10.73

P-value
0.8441
0.4831
0.0011 *

OR
0.87
1.52
7.26

95% CI
0.23
3.34
0.47
4.86
2.22
23.76

1.41
1.19
2.20
1.81
3.27
22.99

0.2344
0.2752
0.1377
0.1787
0.0704
0.0034 *

0.52
1.83
2.17
2.77
3.68

0.18
0.62
0.78
0.63
0.90

48

1.53
5.44
6.05
12.19
15.09

Table 10. Proposed Components
Risk indicator
S Snore

OSA
Adjusted
Negative Positive
RR OR
(95% CI)
No
55
7 11% 2.04 0.93 (0.21, 3.82)
Yes
70 21 23%
102 20 16% 1.57 2.11 (0.66, 6.72)
23
8 26%

p-value
0.9249

T Tonsillar hypertrophy

No
Yes

O Sleep obstruction

No
Yes

86
8
9% 3.98 7.84 (2.41, 31.41)
39 20 34%

0.0004 *

B BMI percent>85 or <10

No
Yes

45
4
8% 2.85 4.02 (1.28, 15.93)
79 24 23%

0.0155 *

A Age younger than 4, older than 16 No
Yes

111 22 17% 1.81 4.33 (1.06, 18.34)
14
6 30%

0.0410 *

N Neuro/Muscular disorder

No
Yes

108 24 18% 1.05 3.79 (0.76, 18.29)
17
4 19%

0.1007

G Genetic/Congenital disorder

No
Yes

109 23 17% 1.37 5.03 (1.19, 21.22)
16
5 24%

0.0289 *
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0.2057

Overall
Proportion

1.00

3-severe
2-moderate

0.75

Proportion

1-mild

0.50

0-none
0.25

0.00

0

1

2

3
4
S(T1)OPBANG

STOPBANG

Figure 1. Results for S(T1)OPBANG
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5 6

Figure 2. Receiver Operating Characteristic Curve for S(T1)OPBANG
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Figure 3. Receiver Operating Characteristic Curve for S(T2)OPBANG
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Figure 4. BMI Percentile for Age versus Age
Legend: AHI none ○, mild ● moderate ● and 12=severe ●
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Appendix 1
Data Sheet

Obstructive Sleep Apnea in Children

Study #______

Demographics
1.
2.

Date of PSG _______________________
Age at time of PSG (__y__m) ________________
(<4 or >12 yrs= 1, otherwise 0)

3.
4.

Race (Choose one): Caucasian, African american, Asian, Hispanic other:_________________
Gender (M or F) ____________

Sleep Center Information
5.
6.
7.
8.

Snore (No, Yes, unknown) _______________
Tonsillar hypertrophy (No, Yes, unknown) ________________
Obstruction (No, Yes, unknown) _______________
Daytime neurobehavioral symptoms (No, Yes, unknown)_________________

a.
b.
c.
d.

ICD 314.01 Attention deficit disorder with Hyperactivity
ICD 314.00 Attention deficit disorder without mention of Hyperactivity
ODD oppositional defiant disorder
_________________________________

9. Excessive tiredness/irritability during daytime (No, Yes, unknown) ______________
10. Weight __lb/kg and Height: ____inches/cm
BMI if provided in chart: ________________
BMI calculated by recorders:______________
11. Neuro/Muscular disorder(fill in):________________________________
12. Genetic/Congenital disorder (fill in):_____________________________
13. Epworth scale __________________________________
14. AHI score_______________________

54

Appendix 2
VCU Center for Sleep Medicine Questionnaire
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Appendix 3
Epworth Scale
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